| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Candel Therapeutics, Inc. | Chief Financial Officer | Common Stock | 10,125 | $9,113 | $0.9000 | 29 Jul 2021 | Direct |
| Candel Therapeutics, Inc. | Chief Financial Officer | Stock Option (Right to Buy) | 110,000 | 28 Feb 2022 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| CADL | Candel Therapeutics, Inc. | 28 Feb 2022 | 1 | $0 | 4 | Chief Financial Officer | 01 Mar 2022, 17:40 |
| CADL | Candel Therapeutics, Inc. | 29 Jul 2021 | 1 | +$81,000 | 4 | Chief Financial Officer | 02 Aug 2021, 20:06 |
| CADL | Candel Therapeutics, Inc. | 26 Jul 2021 | 0 | $0 | 3 | Chief Financial Officer | 26 Jul 2021, 21:26 |